Literature DB >> 8084014

The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis.

S Niewiesk1, S Daenke, C E Parker, G Taylor, J Weber, S Nightingale, C R Bangham.   

Abstract

Human T-cell leukemia virus type I (HTLV-1) causes T-cell leukemia and tropical spastic paraparesis (TSP) in a minority of infected people, whereas the majority remain healthy. No association between a particular HTLV-I sequence and disease manifestation has been found in previous studies. We studied here the sequence variability of the gene for the HTLV-I Tax protein, which is the dominant target antigen of the very strong cytotoxic T-lymphocyte response to the virus. In HTLV-I infection, the intraisolate nucleotide variability is much greater than the variability between isolates. The predicted protein sequence of Tax was significantly more variable in the healthy seropositive individuals' provirus than in those of the patients with TSP. Thus, tax sequence heterogeneity, rather than the presence of particular sequences, distinguishes healthy HTLV-I-seropositive individuals from patients with TSP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8084014      PMCID: PMC237103     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Envelope gene sequence of HTLV-1 isolate MT-2 and its comparison with other HTLV-1 isolates.

Authors:  G S Gray; M White; T Bartman; D Mann
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

2.  Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions.

Authors:  M Nei; T Gojobori
Journal:  Mol Biol Evol       Date:  1986-09       Impact factor: 16.240

3.  Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type I carriers in Saga, Japan.

Authors:  S Tokudome; O Tokunaga; Y Shimamoto; Y Miyamoto; I Sumida; M Kikuchi; M Takeshita; T Ikeda; K Fujiwara; M Yoshihara
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

4.  Molecular cloning and complete nucleotide sequence of an adult T cell leukaemia virus/human T cell leukaemia virus type I (ATLV/HTLV-I) isolate of Caribbean origin: relationship to other members of the ATLV/HTLV-I subgroup.

Authors:  K T Malik; J Even; A Karpas
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

Review 5.  A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes.

Authors:  W H Li; C I Wu; C C Luo
Journal:  Mol Biol Evol       Date:  1985-03       Impact factor: 16.240

6.  The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.

Authors:  J E Kaplan; M Osame; H Kubota; A Igata; H Nishitani; Y Maeda; R F Khabbaz; R S Janssen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

7.  Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I.

Authors:  L Ratner; S F Josephs; B Starcich; B Hahn; G M Shaw; R C Gallo; F Wong-Staal
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

8.  Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates.

Authors:  S Daenke; S Nightingale; J K Cruickshank; C R Bangham
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

9.  Nucleotide sequence analysis of a provirus derived from HTLV-1-associated myelopathy (HAM).

Authors:  A Tsujimoto; T Teruuchi; J Imamura; K Shimotohno; I Miyoshi; M Miwa
Journal:  Mol Biol Med       Date:  1988-02

10.  Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously.

Authors:  C E Parker; S Nightingale; G P Taylor; J Weber; C R Bangham
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more
  26 in total

Review 1.  HTLV-1 infections.

Authors:  C R Bangham
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

Review 2.  An introduction to lymphocyte and viral dynamics: the power and limitations of mathematical analysis.

Authors:  Becca Asquith; Charles R M Bangham
Journal:  Proc Biol Sci       Date:  2003-08-22       Impact factor: 5.349

Review 3.  The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth.

Authors:  D M D'Agostino; M Silic-Benussi; H Hiraragi; M D Lairmore; V Ciminale
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

Review 4.  Cytotoxic T cells and viral hepatitis.

Authors:  F V Chisari
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

Review 5.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

Review 6.  Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control.

Authors:  Charles R M Bangham
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

Review 7.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

8.  Evolution in a chronic RNA virus infection: selection on HTLV-I tax protein differs between healthy carriers and patients with tropical spastic paraparesis.

Authors:  S Niewiesk; C R Bangham
Journal:  J Mol Evol       Date:  1996-04       Impact factor: 2.395

9.  HLA class I binding of HBZ determines outcome in HTLV-1 infection.

Authors:  Aidan Macnamara; Aileen Rowan; Silva Hilburn; Ulrich Kadolsky; Hiroshi Fujiwara; Koichiro Suemori; Masaki Yasukawa; Graham Taylor; Charles R M Bangham; Becca Asquith
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

10.  High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.

Authors:  Peter K C Goon; Tadahiko Igakura; Emmanuel Hanon; Angelina J Mosley; Becca Asquith; Keith G Gould; Graham P Taylor; Jonathan N Weber; Charles R M Bangham
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.